Cargando…

Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers

PURPOSE: The aim of this study was to evaluate 1-year quantitative changes in specific inflammatory parameters on optical coherence tomography (OCT) / optical coherence tomography angiography (OCTA) in diabetic macular edema (DME) treated with subthreshold micropulse laser (SMPL). METHODS: Thirty-se...

Descripción completa

Detalles Bibliográficos
Autores principales: Vujosevic, Stela, Toma, Caterina, Villani, Edoardo, Brambilla, Marco, Torti, Emanuele, Leporati, Francesco, Muraca, Andrea, Nucci, Paolo, De Cilla, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533727/
https://www.ncbi.nlm.nih.gov/pubmed/33062394
http://dx.doi.org/10.1167/tvst.9.10.31
_version_ 1783590193009262592
author Vujosevic, Stela
Toma, Caterina
Villani, Edoardo
Brambilla, Marco
Torti, Emanuele
Leporati, Francesco
Muraca, Andrea
Nucci, Paolo
De Cilla, Stefano
author_facet Vujosevic, Stela
Toma, Caterina
Villani, Edoardo
Brambilla, Marco
Torti, Emanuele
Leporati, Francesco
Muraca, Andrea
Nucci, Paolo
De Cilla, Stefano
author_sort Vujosevic, Stela
collection PubMed
description PURPOSE: The aim of this study was to evaluate 1-year quantitative changes in specific inflammatory parameters on optical coherence tomography (OCT) / optical coherence tomography angiography (OCTA) in diabetic macular edema (DME) treated with subthreshold micropulse laser (SMPL). METHODS: Thirty-seven patients / eyes with previously treatment-naïve DME treated with SMPL were prospectively evaluated at 3, 6, and 12 months. Fifteen fellow eyes with only microaneurysms (MAS) not eligible for treatment were controls. Evaluated OCT / OCTA parameters included: central macular thickness (CMT); hyper-reflective retinal spots (HRS); disorganization of inner retinal layers (DRILs); MA in the superficial / deep capillary plexuses (SCP/DCP); cysts in the area at the SCP / DCP; and macular perfusion parameters (MATLAB, version 2017b). RESULTS: In the treated group, mean best corrected visual acuity (BCVA) progressively increased from 69.4 ± 12.0 to 76.0 ± 9.1 Early Treatment Diabetic Retinopathy Study (ETDRS) letters (P < 0.001) at 12 months; HRS decreased from baseline (80.75 ± 20.41) at 3 (73.81 ± 17.1, P = 0.002), 6 (69.16 ± 16.48, P < 0.0001), and 12 months (66.29 ± 18.53, P < 0.0001). MA decreased at 3 months in the DCP (P = 0.015), at 6 and 12 months in both plexuses (P ≤ 0.0007). BCVA, HRS, and MA remained stable in the controls during all follow-ups. DRIL was present in 18 of 37 patients at baseline and progressively decreased from 557.0 ± 238.7 to 387.1 ± 282.1 μm (P = 0.01). The area of cyst decreased both in the SCP (P = 0.03) and the DCP (P = 0.02). CMT and perfusion parameters did not change. CONCLUSIONS: SMPL reduced the number of HRS (sign of activated microglia cells in the retina), MA, DRIL extension, and the area of cysts. Further studies are needed to confirm these preliminary data on the anti-inflammatory effect of SMPL, and to explore the mechanism of action. TRANSLATIONAL RELEVANCE: The follow-up of OCT/OCTA noninvasive biomarkers offers a unique insight in the mechanism of laser action, suggesting an anti-inflammatory effect of SMPL.
format Online
Article
Text
id pubmed-7533727
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-75337272020-10-13 Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers Vujosevic, Stela Toma, Caterina Villani, Edoardo Brambilla, Marco Torti, Emanuele Leporati, Francesco Muraca, Andrea Nucci, Paolo De Cilla, Stefano Transl Vis Sci Technol Article PURPOSE: The aim of this study was to evaluate 1-year quantitative changes in specific inflammatory parameters on optical coherence tomography (OCT) / optical coherence tomography angiography (OCTA) in diabetic macular edema (DME) treated with subthreshold micropulse laser (SMPL). METHODS: Thirty-seven patients / eyes with previously treatment-naïve DME treated with SMPL were prospectively evaluated at 3, 6, and 12 months. Fifteen fellow eyes with only microaneurysms (MAS) not eligible for treatment were controls. Evaluated OCT / OCTA parameters included: central macular thickness (CMT); hyper-reflective retinal spots (HRS); disorganization of inner retinal layers (DRILs); MA in the superficial / deep capillary plexuses (SCP/DCP); cysts in the area at the SCP / DCP; and macular perfusion parameters (MATLAB, version 2017b). RESULTS: In the treated group, mean best corrected visual acuity (BCVA) progressively increased from 69.4 ± 12.0 to 76.0 ± 9.1 Early Treatment Diabetic Retinopathy Study (ETDRS) letters (P < 0.001) at 12 months; HRS decreased from baseline (80.75 ± 20.41) at 3 (73.81 ± 17.1, P = 0.002), 6 (69.16 ± 16.48, P < 0.0001), and 12 months (66.29 ± 18.53, P < 0.0001). MA decreased at 3 months in the DCP (P = 0.015), at 6 and 12 months in both plexuses (P ≤ 0.0007). BCVA, HRS, and MA remained stable in the controls during all follow-ups. DRIL was present in 18 of 37 patients at baseline and progressively decreased from 557.0 ± 238.7 to 387.1 ± 282.1 μm (P = 0.01). The area of cyst decreased both in the SCP (P = 0.03) and the DCP (P = 0.02). CMT and perfusion parameters did not change. CONCLUSIONS: SMPL reduced the number of HRS (sign of activated microglia cells in the retina), MA, DRIL extension, and the area of cysts. Further studies are needed to confirm these preliminary data on the anti-inflammatory effect of SMPL, and to explore the mechanism of action. TRANSLATIONAL RELEVANCE: The follow-up of OCT/OCTA noninvasive biomarkers offers a unique insight in the mechanism of laser action, suggesting an anti-inflammatory effect of SMPL. The Association for Research in Vision and Ophthalmology 2020-09-30 /pmc/articles/PMC7533727/ /pubmed/33062394 http://dx.doi.org/10.1167/tvst.9.10.31 Text en Copyright 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Vujosevic, Stela
Toma, Caterina
Villani, Edoardo
Brambilla, Marco
Torti, Emanuele
Leporati, Francesco
Muraca, Andrea
Nucci, Paolo
De Cilla, Stefano
Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title_full Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title_fullStr Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title_full_unstemmed Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title_short Subthreshold Micropulse Laser in Diabetic Macular Edema: 1-Year Improvement in OCT/OCT-Angiography Biomarkers
title_sort subthreshold micropulse laser in diabetic macular edema: 1-year improvement in oct/oct-angiography biomarkers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533727/
https://www.ncbi.nlm.nih.gov/pubmed/33062394
http://dx.doi.org/10.1167/tvst.9.10.31
work_keys_str_mv AT vujosevicstela subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT tomacaterina subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT villaniedoardo subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT brambillamarco subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT tortiemanuele subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT leporatifrancesco subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT muracaandrea subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT nuccipaolo subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers
AT decillastefano subthresholdmicropulselaserindiabeticmacularedema1yearimprovementinoctoctangiographybiomarkers